Cognex Corporation
CGNXTechnologyNASDAQScientific & Technical Instruments · Last scanned Sep 9, 2026
Scan Results
Daily timeframePart of the technology sector, Cognex Corporation (CGNX) is listed under Scientific & Technical Instruments. Valued at $10.47B, CGNX is a large-cap name in its sector. Its machine vision products are used to automate the manufacture and distribution of discrete items, such as mobile phones, automotive components, and e-commerce packages, by locating, identifying, inspecting, and measuring them.
Market Cap
$10.47B
Beta
1.49
P/E (TTM)
59.84
P/E (Fwd)
30.74
EPS (TTM)
$1.04
EPS (Fwd)
$2.02
ROE
11.2%
ROA
7.1%
Cash
$404.4M
Total Debt
$72.5M
Free CF
$195.7M
52W Change
40.2%
Annual Financials
Cash vs Debt
Where CGNX stands vs its 150-day and 200-day moving averages
As of the August 26, 2026 close, CGNX finished 4.07% above its 150-day moving average ($57.48) and 14.01% above its 200-day moving average ($52.47). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CGNX overbought or oversold?
At the August 26, 2026 close, CGNX's RSI(14) was 29.9, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Cognex Corporation holds $404.4M in cash against $72.5M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Annual free cash flow of $195.7M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 11.2%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 7.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $1.01B (2022) to $994.4M (2025).
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CGNX.